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Abstract 
 Introduction. Cardiovascular disease is one of the most prevalent risk factors for 
mortality in the world. Pulse wave velocity (PWV), a reflection of arterial stiffness has been 
shown to positively correlate with the advancement of cardiovascular disease and may be the 
best indicator of arterial health. There is an emerging technology revolution with a goal of 
monitoring fitness and health with a variety of mobile devices, often wearable in nature. The 
Withings platform is one of the most prevalent in this field with their Body Cardio scale 
dominating the market as the first comprehensive monitoring of whole-body health. This 
diagnostic bathroom scale is designed to be brought into homes with the goal of early 
recognition of increased pulse transit times. The scale detects individual pulse waves via a 
proprietary algorithm, yet due to regional differences in fat distribution, the proprietary algorithm 
may not account for this correlating factor. Also, no home device has been tested against 
laboratory gold standards with a goal of elucidating sex differences. Therefore, the purpose of 
this study was to compare the Body Cardio scale for accurate analysis of PWV compared to a 
laboratory gold standard (Sphygmocor, AtCor Medical). We hypothesized that the Body Cardio 
would yield greater variability lending to increased error of measure. Methods. Twenty healthy, 
normotensive, college-aged individuals (10 male, 10 female) utilized the Body Cardio scale in a 
laboratory setting to obtain body composition data and three independent PWV measurements, 
each followed by a standing PWV measurement with the SphygmoCor XCEL. Body 
composition data was obtained from the BodPod via air displacement plethysmography. All 
procedures were counterbalanced and occurred between 6am and 10am on weekdays. The 
subjects were instructed to avoid strenuous exercise and consumption of alcohol or caffeine 
within 12 hours of data collection. The surface of the Body Cardio scale was dampened to allow 
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for maximal conduction and subjects were instructed to remain silent and still during all 
measurements. Results. Though the Body Cardio scale underestimated PWV respective to 
SphygmoCor in males by 0.703 m/s (6.3 ± 0.179 m/s vs. 6.9 ± 0.244 m/s) and 0.653 m/s in 
females (5.9 ± 0.179 m/s and 6.6 ± 0.244 m/s), though no significant differences were observed 
(P > 0.05). Discussion. It was anticipated that different regional distributions of fat across sexes 
would impact the accuracy of PWV measurement with the Body Cardio scale, yet no significant 
differences were observed. The ability of the Body Cardio to accurately measure pulse wave 
velocity at home for both sexes, despite these regional mass variations lends great ecological 
significance and promises a wider scope of real-time information for an individual’s physician. 
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Chapter 1: Introduction 
 Cardiovascular disease (CVD) is widely known as the leading cause of death in the 
United States. The pervasiveness and severity of this disease in younger populations increases 
with each passing year. Assessment of cardiovascular health in a clinical setting is multi-faceted 
and dynamic; technology is rapidly changing in an effort to maintain pace with the failing hearts 
and vessels of individuals worldwide. The development of atherosclerotic plaques is credited for 
the decreased arterial elasticity in those with CVD, thus vessel distensibility within a cardiac 
cycle is greatly disrupted. Perhaps one of the most influential recent developments in the field of 
cardiology was the ability to evaluate the elasticity of vessels, and thus derive information about 
vessel status. Pulse wave velocity (PWV), a measure of the pulse transit time of a single bolus of 
blood, is a vastly utilized measure of vessel health, particularly in preventative cardiovascular 
medicine. Arterial stiffness, as determined by PWV, is now an invaluable biomarker in the 
determination of cardiovascular health status in preventative, diagnostic, and retroactive 
medicine (Vlachopoulos 2014, 2010).  
Pulse Wave Velocity 
Elucidation of pulse transit times, whether in a laboratory or clinical setting, provides 
invaluable information regarding vessel health from the perspective of elasticity and overall 
resistance. Low PWV values are inversely related with arterial distensibility. In individuals 
below 30 years of age, a standard range of reference is 4.7-7.6 m/s with females trending lower 
than males (Mattace-Raso 2010). An elevated PWV value serves as an indicator of stiffening in 
the central arterial system. A minimal, albeit detectable, stiffening throughout the entire 
vasculature is expected with aging as a result of a variety of physiological processes. However, 
within the central arterial system, specifically the arterial trunk, an increase in stiffness is known 
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to contribute to a decline in cardiovascular health (Laurent 2001, Shirwany 2010, Vlachopoulos 
2010). Appreciating this decrease in distensibility provides invaluable insights to current 
cardiovascular health in nearly all populations.  
Body Composition 
 The drastic increase in cardiovascular disease prevalence within the past decade is far 
from unique. The persistence and exponential rise of obesity, both childhood and adult, has 
created a sector of the medical field entirely devoted to metabolic diseases and their implications. 
In an age where technology is at the core of nearly every aspect of life, the implementation of 
weight tracking applications has been revolutionary in weight-loss strategies and practices. 
Through a physiological lens, an overweight or obese individual carries a much greater risk for 
both all-cause and cardiovascular mortality, often in excess of a 4.0 relative risk factor (Lee 
1999).  
Superfluous weight, most commonly resulting from a poor diet and sedentary lifestyle, 
can lead to the development of increased serum cholesterol levels, hypertension, and severely 
reduced vessel elasticity. Understanding the impacts of obesity on cardiovascular health is 
clinically essential, but at the patient level, simple tracking of weight gain and weight loss trends 
has proven to be beneficial when striving towards fitness goals (Spring 2013).  
SphygmoCor XCEL 
Until recent developments, the determination of pulse transit times was only achievable 
in a laboratory or clinical setting. The SphygmoCor XCEL from AtCor Medical (New South 
Wales, Australia) is well recognized as the leading device in the field of pulse transit times, 
having been validated against the ARTERY Society’s PWV Validation guidelines and cited 
extensively in peer-reviewed research articles (Butlin 2013, Butlin 2017, Reshetnik 2017). This 
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device utilizes applanation tonometry at the carotid artery to yield an arterial waveform. 
Volumetric flow determination through a cuff at the femoral artery is combined with measured 
transit time between these two points as a unit per travel distance, a value that is obtained 
through manual measurement of the difference between various appreciated physiological 
landmarks (Butlin 2017). 
Withings Body Cardio Scale 
This recent development in clinical interpretation of arterial distensibility has coincided 
with an era of wellness-based technological advancement. Various companies have advanced 
their wristwatch and cellphone application platforms to include advanced cardiovascular data at 
the simple touch of a button. Withings is a strong competitor in this field, boasting an advanced 
bathroom scale that is one-of-a-kind. The Withings Body Cardio scale is designed for use in the 
home and can be purchased for less than $150 online. The scale provides weight and BMI 
measurements, triple component body composition, heart rate, and pulse wave velocity data. 
This data is tracked within the HealthMate application for up to eight different individuals per 
scale. Trending data is designed for interpretation both by the patient at home and by a clinician, 
utilizing the advantageous implementation of an online Patient Portal at most major medical 
centers worldwide (Griffin 2016). For example, if a patient noted an increasing trend in PWV 
over a period of several weeks, they could easily export this information from the HealthMate 
application to their Patient Portal as a direct message to their physician to receive real-time 
feedback on indications for their cardiovascular health. 
This advanced bathroom scale shows promise to serve as an easily accessible and cheaper 
alternative to the clinical grade determination of PWV. Though PWV is reported simply on the 
Body Cardio scale, the biomechanical mechanisms behind this process are quite complex. A 
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combination of ballistocardiography (BCG) and impedance plethysmography (IPG) enables the 
scale to determine aortic-leg PWV. When the user stands on the scale and minimizes motion, 
BCG can detect the extremely slight weight variations that cycle in direct concordance with the 
systolic ejection of a bolus of blood. This minute variation corresponds to the opening of the 
aortic valve, the timing of which is recorded for calculation (Campo 2017). IPG, however, 
measures small changes in electrical resistance. These cyclic variations are again coordinated to 
the cardiac cycle with the determination of the pulse wave arrival in the feet. The time-lapse 
between the ventricular ejection and planar bolus arrival allows for determination of PWV.  
Though innovative in nature, the Body Cardio scale calculates PWV using a proprietary 
algorithm that determines pulse transit times without consideration of sex. Both IPG and BCG 
are affected by body mass distribution patterns (Campo 2017, Van Bortel 2012). It is understood 
that men and women have different regional fat mass profiles, and yet the proprietary algorithm 
for PWV determination remains non-discriminatory to sex. The lack of differentiation for 
determination of PWV raises a simple question: can the Body Cardio scale provide an accurate 
analysis of PWV in both sexes? The Body Cardio scale, to our knowledge, has not yet been 
tested against laboratory gold standards and thus sex differences in PWV variability have not 
been elucidated. The primary purpose of this study was to validate the Withings Body Cardio 
scale for accurate analysis of PWV with a specific focus on regional fat distribution variations by 
sex. We hypothesized that the mobile device would lend more variability, thus translating to a 
higher margin of error when compared to the gold-standard Sphygmocor XCEL. A significant 
error in this technology could translate to unnecessary clinical alarm in response to falsely 
elevated readings, or a lack of medical action due to erroneously low PWV values. Prior to 
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implementation as an extension of clinical care, validation of this technology is essential for all 
populations.  
Though not the focus of this study, the Withings platform has also provided a user-
friendly way to track much more than simply body weight. With detailed analyses of body 
composition in a triple-component manner, users receive data relating to fat mass, fat free mass, 
bone weight, and more. These data are simple to interpret and directly link to the HealthMate 
application for long-term tracking that can supplement weight loss and fitness goals. When 
paired with PWV data integrated into the same easy-to-use application, both providers and 
patients alike can receive a detailed picture regarding the state of the cardiovascular system.  
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Chapter 2: Methods 
Participants 
 Twenty (10 male, 10 female) normotensive, college-aged individuals from the Boone, 
North Carolina area were recruited to participate in this study. The participants ranged from 18-
25 years old with a mean age of 21.80 ± 1.96 years. All participants were physically active 
according to ACSM Physical Activity Guidelines (U.S. Department 2018). Exclusion criteria 
were a history of cardiovascular, metabolic, or respiratory disease. Descriptive statistics related 
to study population are included in Table 1. Participants received no monetary compensation for 
their time but were provided with their body composition data report produced by their BodPod 
analysis.  
 
Table 1. Description of study participants. 
 
Study Design  
 The Appalachian State University Institutional Review Board approved all experimental 
procedures (IRB 17-0023). All instrumentation and protocols were thoroughly explained to 
participants and informed consent was obtained and documented. Each participant reported to 
the Vascular Biology and Autonomic Studies Laboratory between 6:00 and 9:00 in the morning. 
Participants were instructed to avoid consumption of alcohol and vigorous activity 12 hours prior 
to arrival time. Upon arrival, anthropometric data was collected, followed by body composition 
measurements via whole-body plethysmography. Participants then either underwent a standing 
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PWV measurement using an applanation tonometer or a PWV reading with the Withings Body 
Cardio scale; this order was counterbalanced throughout the study. The cycle of PWV reading 
was repeated three times.  
Anthropometrics 
 Age and relative physical activity levels were self-reported. Body weight was measured 
using the BodPod platform scale. Height was measured using a stadiometer to the nearest 0.5 cm. 
Body composition was measured via whole-body plethysmography utilizing a BodPod (Life 
Measurement Inc., Concord, CA, USA). Body mass index was calculated as weight divided by 
height (kg/m2) squared. Blood pressure and pulse wave velocity was obtained in the standing 
position utilizing the Sphygmocor XCEL applanation tonometer (AtCor Medical, Itasca, 
Illinois).  
Body Composition 
 Body composition was obtained following standard protocol for air displacement 
plethysmography. Subjects dressed in minimal clothing (spandex, compression shorts, etc.) and a 
swim cap and were instructed to breathe normally as measurements were taken. Residual lung 
volume was estimated utilizing the Bod Pod software based on race, sex, and height inputs. Body 
mass for input was determined using the Bod Pod beam balance platform scale after calibration. 
Central Arterial Stiffness 
 Pulse wave velocity and augmentation index measurements were obtained using the 
Sphygmocor XCEL. A standing blood pressure was obtained using the Sphygmocor XCEL and 
confirmed with manual auscultation. The tonometer was placed on the right common carotid 
artery and a blood pressure cuff was placed on the right femoral artery to occlude flow and 
measure pulse transit time. A basic tape measure was used to obtain measurements from the 
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pulse point in the carotid artery to the sternal notch, from the sternal notch to the superior line of 
the femoral cuff, and from the femoral artery at the inguinal crease to the superior line of the 
femoral cuff based on appreciation of the aforementioned landmarks. These measurements were 
entered into the Sphygmocor XCEL along with subject height, sex, and age and used to calculate 
pulse wave velocity with the applanation tonometer. Quality control (QC) index was met with 
each accepted pulse wave measurement. If QC index failed, the measurement was repeated.  
Body Cardio Scale 
 Subjects were entered into the HealthMate application on a laboratory computer prior to 
beginning PWV measurement. Five scale measurements were required for calibration of PWV 
measurement, all of which were completed prior to PWV measurement. The scale was dampened 
with a wet rag to simulate the humid environment of a home bathroom prior to each 
measurement. Subjects were instructed to step on the scale and stand still with their weight 
evenly distributed on both feet without speaking for the duration of the measurement.  
Statistical Analysis 
 All data are presented as mean ± SD and was collected during the same time of day. An 
rmANOVA was employed for comparisons between Sphygmocor and Nokia hardware device 
output with subject sex as the grouping variable. Mauchly’s test for sphericity was completed to 
ensure normality. All descriptive data was compared by a univariate analysis between sexes.  
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Chapter 3: Results 
Statistical Analysis 
 Data was collected from each device’s respective database (SphygmoCor, Withings 
HealthMate). These data were de-identified and complied into a secure database. The average of 
three obtained pulse wave velocity measurements were utilized for analysis. A Bland-Altman 
analysis was conducted. A one-sample t-test was performed to derive mean difference and 95% 
confidence intervals for the respective Bland-Altman plots. In an effort to evaluate for 
proportional bias and determine Pearson correlation coefficient, regression analyses were 
performed. The error is presented as a percentage of the overall mean as a Mean Absolute 
Percent Error (MAPE) and serves as an indication of the degree of error. Subsequently a repeated 
measures ANOVA was utilized to analyze variance as a product of sex differences between the 
respective devices.  
Blood Pressure 
 Blood pressure was obtained prior to each measurement of PWV with the SphygmoCor 
sphygmomanometer.  These data are presented in Table 2. In males, a mean blood pressure of 
114/64 was obtained. The mean female blood pressure was 109/63.  
 
Table 2. Blood pressure data by sex. All values provided in mmHg. SD: standard deviation. 95% 
CI: 95% confidence interval.  
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Body Composition 
 A two-component method of body composition was derived from air displacement 
plethysmography (BodPod). These data are presented in Table 3, stratified by sex, and are 
graphically depicted in Figures 2 and 3. A 95% confidence of (-0.41, 0.18) is depicted in Figure 
4. Regression analysis yielded a Pearson correlation coefficient of 0.47. with evidence of a 
proportional bias (P<0.05). A 0.15% MAPE was calculated.  
 
Table 2. Body composition data. All values listed in kg. BM: body mass, FM: fat mass, FFM: fat 
free mass, SD: standard deviation. 
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Figure 2. Body composition data. All values listed in kg. Standard error bars represent 95% 
confidence interval. BM: total body mass. FM: fat mass. FFM: fat-free mass. N=20. 
 
 
 
Figure 3. (A) Fat mass and fat free mass divisions of male and female subjects (n=20) as 
reported by Body Cardio scale in kg. (B) Fat mass and fat free mass divisions of male and female 
subjects (n=20) as reported by BodPod.  
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Figure 4. Mean Difference and 95% confidence intervals of body composition between 
Withings Body Cardio scale and SphygmoCor, AtCor Medical Tonometer.  
 
Pulse Wave Velocity 
 Table 3 depicts mean pulse wave velocity (PWV) and standard error for each device by 
sex. Figure 4 graphically displays the aforementioned data. The mean difference between devices 
was established to be 0.68 m/s; 95% confidence intervals were (-0.16, 1.51) as is depicted in 
Figure 5. A Pearson correlation coefficient of 0.49 was derived from regression analyses and 
evidence of proportional bias (P < 0.05). A repeated measures ANOVA indicated no effect of 
sex on PWV measurement between the SphygmoCor and Withings Body Cardio. A 9.7% MAPE 
was calculated.  
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Table 3. Pulse Wave Velocity (PWV) data from Withings Body Cardio scale and SphygmoCor 
Applanation Tonometry. All values depicted in m/s. SD: standard deviation, SE: standard error, 
Min: minimum, Max: maximum, 95% CI: 95% confidence interval. 
 
 
 
Figure 5. Pulse Wave Velocity of Withings Body Cardio scale and SphygmoCor AtCor Medical 
Tonometer (reference device) by sex and combined. All values represented in m/s. 
 
 
 17 
 
Figure 6. Mean Difference and 95% confidence intervals of Pulse Wave Velocity between 
Withings Body Cardio scale and SphygmoCor, AtCor Medical Tonometer.  
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Chapter 4. Discussion 
 This study aimed to assess the accuracy of pulse wave velocity (PWV) measurement of 
the Withings Body Cardio scale utilizing the SphygmoCor applanation tonometry as a reference. 
These accuracies were evaluated with specific regard for the implications of sex differences in 
regional fat distribution as related to PWV measurement. To the knowledge of the research team, 
no prior validation of this technology has been completed to date. Previous studies have 
indicated that the implementation of wearable and home wellness technologies provide 
beneficial results towards goals in those fields (Pevnick 2018). Companies such as Withings, 
Apple, Garmin, and Fitbit are rapidly expanding their platforms products to provide consumers 
with real-time health data from the technologies utilized use on a daily basis. The Body Cardio 
scale, sold by Withings, is perhaps one of the most advanced bathroom scales of this wellness 
technology movement, promising information about body weight, body composition, heart rate, 
and PWV. The utilization of PWV measurements from the Body Cardio scale shows promise 
when considering a real-time analysis of vessel health at home. Prior to implementation into 
clinical practice, the accuracy of these data must be validated for both sexes. An assessment of 
this ground-breaking technology was both the charge and aim of this research.   
 The implications of elevated pulse transit times are well understood and are thus 
discussed briefly in this work. As an indirect measure of arterial distensibility, elevated pulse 
transit times serve as an indication of stiffer arteries (Aortic Stiffness Predictor, PWV 
Retrospective). This loss in central arterial elasticity is positively correlated with an increased 
risk of all-cause mortality and cardiovascular mortality (Laurent 2001). During the systolic 
component of pulsatile flow, the arterial pressure drastically increases as each bolus of blood is 
pushed through the vasculature. Arterial elasticity allows for the absorption of this increased 
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pressure. Through the measurement of pulse wave velocity, distensibility can be derived 
inversely to speed. A slower pulse wave velocity indicates a higher vessel elasticity, and thus a 
healthier cardiovascular system (Asmar 1995).  
 Blood Pressure. Blood pressure was collected as a preliminary analysis of vessel health. 
Hypertension has been directly linked to a reduction in vascular elasticity and was thus analyzed 
to ensure normality of vessel condition in this population. The average blood pressure of 111/64 
indicated a normotensive population (Pickerning, 1982). In recruiting a normotensive subject 
group, the validity of PWV measurements with the Body Cardio scale in comparison to the 
SphygmoCor could be evaluated without adjustment for a confounding hypertensive state. 
 Body Composition. Evaluation of body composition as determined by the Body Cardio 
scale in comparison to the BodPod was completed and no significant difference was observed in 
the determination of fat and fat free masses across sexes. It is well understood that men and 
women have differing regional fat distributions and thus it was hypothesized that this would 
heavily impact the ability of the bioelectrical impedance (BIA) mechanism of proprietary 
analysis for PWV (Kyle 2004). Body composition analysis is not discussed in detail in this work 
but yielded a confidence that erroneous body mass measurements would not affect the variability 
of the PWV measurements. Though our population retained relatively low body fat percentages 
(13.1% combined), the absence of significant variation between Body Cardio and SphygmoCor 
PWV values indicated that the Body Cardio scale is not negatively affected by varying regional 
fat distributions.  
 Pulse Wave Velocity. The ARTERY society has provided an “acceptable” accuracy rating 
in difference of PWV measurements when validating devices. A mean difference less than or 
equal to 1.0 m/s and a standard deviation of less than or equal to 1.5 m/s provides an indication 
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of relative accuracy. A mean difference of 0.68 m/s and 0.57 m/s (men and women respectively) 
is within acceptable agreement according to the ARTERY guidelines, and thus can be accepted 
as a clinically non-significant variation (Wilkinson 2010). The confirmed accuracy of the Body 
Cardio scale PWV measurements as determined by our research provides exceptional clinical 
promise for implementation.  
Clinical Application. It should be noted that the Body Cardio scale reported PWV values 
lower than those obtained from the SphygmoCor tonometer in nearly every subject. Though 
these data were within a physiologically reasonable range, this discrepancy should be 
appreciated when utilizing the Body Cardio scale for clinical application. A lack of statistical 
difference between male and female populations also shows promise for extrapolation to other 
subgroups utilizing this scale.  
Limitations and Future Research. This study was limited first and foremost by population 
size. A secondary round of investigation and data analysis could provide more robust and 
informative data. Our population was composed largely of similar individuals – aerobically 
active college-aged individuals, often with a high level of performance-based fitness. 
Recruitment of overweight, sedentary individuals of the same age group could provide a 
beneficial reference for variation in this population. Understanding the data in this 
subpopulation, specifically variations from reference sources, could also provide much needed 
conclusions prior to extrapolation into the larger clinical population.  
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